fashion -WSS

fashion

author：leisure time 2025-09-28 00:54:05 - browse：16

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

WSS

What affirmative action's end means to a medical student

Use doctors trained outside the U.S. to ease the physician shortage

Use doctors trained outside the U.S. to ease the physician shortage

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

A letter from the executive editor: The 2023 STATUS List

What affirmative action's end means to a medical student

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

The cancer drug shortage isn’t new — and neither are the solutions

Being 'nonadherent' patient made me a more empathetic doctor

Cancer drug shortages should be causing more outrage

'Screen and refer' systems are hurting patients

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Prescription digital therapeutics are key to pharma’s future

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Skip the lead apron during X

Walensky prepares to leave CDC — and Congress — behind

What American doctors can learn from their Israeli counterparts

entertainment

Why Novartis is changing the name of its research labs

Why Novartis is changing the name of its research labs

'Screen and refer' systems are hurting patients

A letter from the executive editor: The 2023 STATUS List

UpToDate has a racism problem: Dr. Stanley Goldfarb

NIH nominee Bertagnolli will get October confirmation hearing

Wikipedia

focus

leisure time

leisure time